Clinical Trials Directory

Trials / Unknown

UnknownNCT01586715

Stem Cells Treatment for Extremely Complex Fistulae (HULPCIR)

A Phase IIa Clinical Trial to Study the Treatment of the Extremely Complex and Conventional Treatment Resistant Perianal Fistulae With Autologous Stem Cells From Lipoaspirate

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Instituto de Investigación Hospital Universitario La Paz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the practicability of the autologous e-ASC (Autologous Stem Cells) for the treatment of extremely complex and treatment resistant perianal fistulae.

Conditions

Interventions

TypeNameDescription
DRUGAdipose-derived stem cells without expandedAdministration will be intralesional injection of cells suspension. They will be placed into fistula walls

Timeline

Start date
2012-03-01
Primary completion
2013-05-01
Completion
2013-12-01
First posted
2012-04-27
Last updated
2012-04-27

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01586715. Inclusion in this directory is not an endorsement.

Stem Cells Treatment for Extremely Complex Fistulae (HULPCIR) (NCT01586715) · Clinical Trials Directory